论文部分内容阅读
目的探析氯吡格雷联合氟伐他汀在脑梗塞治疗中的应用效果。方法采用随机的方法将2013年7月~2016年7月所在科室60例脑梗塞患者分为氯吡格雷组和联合组进行统计分析,每组实验样本确定为30例,氯吡格雷组采用氯吡格雷进行治疗,联合组采用氯吡格雷联合氟伐他汀治疗,评估两组患者的治疗效果,日常生活评分,神经功能缺损程度和血脂改善情况。结果相对于氯吡格雷组,联合组患者的治疗效果较高,P<0.05;相对于氯吡格雷组,联合组患者的日常生活评分和神经功能缺损程度较好,P<0.05;相对于氯吡格雷组,联合组的血脂改善情况较好,P<0.05,具备一定的统计学意义。结论采用氯吡格雷联合氟伐他汀治疗脑梗塞患者效果突出,值得临床借鉴。
Objective To investigate the effect of clopidogrel combined with fluvastatin in the treatment of cerebral infarction. Methods Sixty patients with cerebral infarction from July 2013 to July 2016 were randomly divided into clopidogrel group and combination group for statistical analysis. Each group of experimental samples was determined to be 30 cases. Clopidogrel group was treated with chlorine The patients in the combination group were treated with clopidogrel combined with fluvastatin, and the treatment effect, daily life score, degree of neurological deficit, and improvement of blood lipids were evaluated in both groups. Results Compared with clopidogrel group, the treatment effect was higher in the combination group (P <0.05). Compared with the clopidogrel group, the scores of daily living and neurological deficits in the combination group were better (P <0.05) The improvement of blood lipids in the combination group was better than that in the pioglitazone group (P <0.05), with a certain degree of statistical significance. Conclusion Clopidogrel combined with fluvastatin in patients with cerebral infarction is effective and worthy of clinical reference.